Implications of anti‐ganglioside antibodies in isolated dysphagia following COVID‐19 infection: Case series
Brain and Behavior · 2024
DOI: 10.1002/brb3.3514 ↗Kurz gefasst
Fallbericht in der Zeitschrift Brain and Behavior, 2024. Verfasst von Sejoon Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19, Deglutition Disorders, Gangliosides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute.
Themen: Dysphagie
Abstract (Originalsprache)
Background
There have been multiple reports about the occurrence of dysphagia after the contraction of coronavirus disease 2019 (COVID‐19). However, a detailed pathology and epidemiologic relation between COVID‐19 infection and dysphagia have yet to be established. Here, we report three cases of unexplained dysphagia after COVID‐19 diagnosis, with atypical clinical presentations. Case report All patients showed severe isolated lower cranial nerve involvement with dysphagia and aspiration, which required full tube feeding but showed no evidence of limb weakness or sensory symptoms. All tested positive for anti‐ganglioside antibody tests, which all commonly (GD1b, GM1, and GQ1b) are known to have terminal NeuNAc(α2‐3)Gal epitope.
Discussion
We report a series of cases featuring severe, isolated dysphagia post‐COVID‐19 infection, concomitant with positive anti‐ganglioside antibodies. One potential etiology is a variant of Guillain–Barré syndrome. Because only isolated dysphagia with sparing of the facial and extraocular muscles was evident in these cases, we explore the association between anti‐ganglioside antibodies specific to NeuNAc(α2‐3)Gal, which has been frequently associated with the development of bulbar dysfunction. Given that NeuNAc(α2‐3)Gal exhibits an affinity for the spike glycoprotein of SARS‐CoV‐2, a cross‐reaction against NeuNAc(α2‐3)Gal may possibly contribute to isolated dysphagia following COVID‐19 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Rehabilitation Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
ORCID-Profile: Sun Im
Förderung
- Korea Health Industry Development Institute
Zitieren
APA
Kim, S., Bae, J., Park, G. Y., & Im, S. (2024). Implications of anti‐ganglioside antibodies in isolated dysphagia following COVID‐19 infection: Case series. Brain and Behavior. https://doi.org/10.1002/brb3.3514
Vancouver
Kim S, Bae J, Park GY, Im S. Implications of anti‐ganglioside antibodies in isolated dysphagia following COVID‐19 infection: Case series. Brain and Behavior. 2024. doi:10.1002/brb3.3514
BibTeX
@article{Kim2024,
author = {Kim, Sejoon and Bae, Jisun and Park, Geun-Young and Im, Sun},
title = {Implications of anti‐ganglioside antibodies in isolated dysphagia following COVID‐19 infection: Case series},
journal = {Brain and Behavior},
year = {2024},
doi = {10.1002/brb3.3514}
}
EUVIMED